帮助 关于我们

返回检索结果

Age, estimated glomerular filtration rate and ejection fraction score predicts contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease: insight from the TRACK-D study

查看参考文献21篇

文摘 Background The occurrence of contrast induced acute kidney injury (CIAKI) has a pronounced impact on morbidity and mortality.The aim of the present study was to appraise the diagnostic efficacy of age, estimated glomerular filtration rate (eGFR) and ejection fraction (AGEF) score (age/EF(%)+1 (if eGFR was <60 ml?min~(-1)?1.73 m~(-2))) as an predictor of CIAKI in patients with diabetes mellitus (DM) and concomitant chronic kidney disease (CKD).Methods The AGEF score was calculated for 2 998 patients with type 2 DM and concomitant CKD who had undergone coronary/peripheral arterial angiography.CIAKI was defined as an increase in sCr concentration of 0.5 mg/dl (44.2 mmol/L) or 25% above baseline at 72 hours after exposure to the contrast medium.Post hoc analysis was performed by stratifying the rate of CIAKI according to AGEF score tertiles.The diagnostic efficacy of the AGEF score for predicting CIAKI was evaluated with receiver operating characteristic (ROC) analysis.Results The AGEF score ranged from 0.49 to 3.09.The AGEF score tertiles were defined as follows: AGEF_(low) ≤0.92 (n=1 006); 0.92 1.16 (n=992).The incidence of CIAKI was significantly different in patients with low, middle and high AGEF scores (AGEF_(low)=1.1%, AGEF_(mid)=2.3% and AGEF_(high)=5.8%, P<0.001).By multivariate analysis, AGEF score was an independent predictor of CIAKI (odds ratio=4.96, 95% CI: 2.32-10.58, P<0.01).ROC analysis showed that the area under the curve was 0.70 (95% CI: 0.648-0.753, P<0.001).Conclusion The AGEF score is effective for stratifying risk of CIAKI in patients with DM and CKD undergoing coronary/ peripheral arterial angiography.(Clinical Trial identifier: NCT00786136).
来源 Chinese Medical Journal ,2014,127(12):2332-2336 【核心库】
DOI 10.3760/cma.j.issn.0366-6999.20133154
关键词 AGEF score ; contrast induced acute kidney injury ; diabetes ; chronic kidney disease
地址

1. Department of Cardiology, Shenyang Northern Hospital, Liaoning, Shenyang, 110016  

2. Department of Cardiology, Jinan Military 88th Hospital, Shandong, Taian, 271000  

3. Department of Cardiology, Henan Provincial People's Hospital, Henan, Zhengzhou, 450003  

4. Department of Cardiology, First Affiliated Hospital of Lanzhou University, Gansu, Lanzhou, 730000  

5. Department of Cardiology, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing, 400038  

6. Department of Cardiology, The 306th Hospital of People's Liberation Army, Beijing, 100000

语种 英文
文献类型 研究性论文
ISSN 0366-6999
学科 临床医学;内科学
基金 supported by grants from the Key technologies R&D project of Liaoning Province ;  Key Project of National 12th Five-Year Research Program of China
文献收藏号 CSCD:5173793

参考文献 共 21 共2页

1.  Solomon R. Contrast-induced acute kidney injury. Circulation,2010,122:2451-2455 CSCD被引 17 次    
2.  Bouzas-Mosquera A. Contrast-induced nephropathy and acute renal Failure following emergent cardiac catheterization: incidence, risk factors and prognosis. Rev Esp Cardiol,2007,60:1026-1034 CSCD被引 4 次    
3.  McCullough P A. Risk prediction of contrast-induced nephropathy. Am J Cardiol,2006,98:27K-36K CSCD被引 12 次    
4.  Shen W F. Optimizing prevention of contrast-induced acute kidney injury in type 2 diabetic patients with at least moderate renal impairment. Chin Med J,2012,125:3365-3367 CSCD被引 2 次    
5.  Mehran R. A simple risk score for prediction of contrastinduced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol,2004,44:1393-1399 CSCD被引 105 次    
6.  Brown J R. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J,2008,155:260-266 CSCD被引 4 次    
7.  Ando G. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv,2013,82:878-885 CSCD被引 4 次    
8.  Han Y. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol,2013,63:62-70 CSCD被引 1 次    
9.  Di Giulio S. Dialysis outcome quality initiative (DOQI) guideline for hemodialysis adequacy. Int J Artif Organs,1998,21:757-761 CSCD被引 2 次    
10.  Ma Y C. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol,2006,17:2937-2944 CSCD被引 253 次    
11.  American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care,2012,35:11-63 CSCD被引 8 次    
12.  Ranucci M. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation,2009,119:3053-3061 CSCD被引 17 次    
13.  Toutouzas K. Prognostic models for cardiovascular events after successful primary percutaneous coronary intervention. Int J Cardiol,2012,158:168-170 CSCD被引 1 次    
14.  Li J H. Prevention of iodinated contrast-induced nephropathy. Chin Med J,2011,124:4079-4082 CSCD被引 6 次    
15.  Latif F. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv,2009,2:37-45 CSCD被引 2 次    
16.  Capodanno D. Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the age, creatinine, ejection fraction (ACEF) score in patients undergoing percutaneous coronary intervention. Int J Cardiol,2013,168:396-402 CSCD被引 1 次    
17.  Wykrzykowska J J. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trial. Circ Cardiovasc Interv,2011,4:47-56 CSCD被引 3 次    
18.  Patti G. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN (atorvastatin for reduction of myocardial damage during angioplasty-contrastinduced nephropathy) trial. Am J Cardiol,2011,108:1-7 CSCD被引 13 次    
19.  Jo S H. Prevention of radiocontrast mediuminduced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trialda randomized controlled study. Am Heart J,2008,155:499-508 CSCD被引 9 次    
20.  Laville M. Contrast-induced acute kidney injury: how should at-risk patients be identified and managed?. J Nephrol,2010,23:387-398 CSCD被引 8 次    
引证文献 1 篇

1 中华医学会心血管病学分会介入心脏病学组 中国经皮冠状动脉介入治疗指南(2016) 中华心血管病杂志,2016,44(5):382-400
CSCD被引 185 次

显示所有1篇文献

论文科学数据集
PlumX Metrics
相关文献

 作者相关
 关键词相关
 参考文献相关

版权所有 ©2008 中国科学院文献情报中心 制作维护：中国科学院文献情报中心
地址：北京中关村北四环西路33号 邮政编码：100190 联系电话：(010)82627496 E-mail:cscd@mail.las.ac.cn 京ICP备05002861号-4 | 京公网安备11010802043238号